|
|
|
| Daily
News
|
|
Toshiba America Medical Systems, Inc. announced FDA clearance for its high performance Excelart Vantage(TM) ZGV magnetic resonance imaging (MRI) system. The MRI system is immediately available and offers new product sequences, has enhanced image quality and features the Mach 8 processor, increasing reconstruction to 1,300 images per second for more powerful clinical applications.
The Vantage ZGV offers a gradient strength of 33 milliTesla per meter (mT/m), a slew rate of 200 milliTesla per meter per millisecond(mT/m/ms) and delivers the highest homogeneity of any magnet in the industry over the full 50 cm diameter spherical volume (DSV). Field upgrade kits to the new ZGV are available to current Vantage users.
In addition to the ZGV model, the Vantage is available in three other versions offering an ultra-short magnet at 140 cm with linear 30 mT/m gradient strength and a slew rate of 50 mT/m/ms on the AGV, the 86 mT/m/ms on the MGV and 130 mT/m/ms on the XGV.
The new system includes optional packages for cardiac imaging, advanced Echo Planar Imaging (EPI), Perfusion and Diffusion Imaging, Peripheral magnetic resonance angiography (MRA), and SuperFASE (Fast Advanced Spin Echo) imaging. In addition, Toshiba has pioneered research into contrast-free MRA with its Fresh Blood Imaging (FBI) protocol and Body Diffusion.
With Toshiba's patented Pianissimo(TM) technology, which reduces acoustic noise by as much as 90 percent, the MRI system dramatically reduces the most significant cause of patient discomfort and enables clinicians to better utilize all of the system's high-field MRI capabilities including SPEEDER parallel imaging for increased acquisition speed and reduced examination times.
Back
to Daily News
|
|
|
|
